Zobrazeno 1 - 6
of 6
pro vyhledávání: '"Igor Portnov"'
Publikováno v:
The Journal of Maternal-Fetal & Neonatal Medicine. 35:6802-6806
Minimally invasive surfactant therapy (MIST) is a promising mode of administration that offers the potential to limit barotrauma and prevent lung injury in preterm infants with respiratory distress...
Publikováno v:
Archives of Disease in Childhood - Fetal and Neonatal Edition. 107:121-125
Antenatal corticosteroids undoubtedly save many lives and improve the quality of many others. However, the currently accepted dosage schedule has been in place since 1972, and recent studies have suggested that beneficial effects may be seen with les
Autor:
Eric S. Shinwell, Igor Portnov
Publikováno v:
NeoReviews. 15:e426-e429
Neonatal group B streptococcal disease has become less common but still constitutes a major cause of morbidity and mortality. Around the world, a variety of preventive strategies are in place with varying degrees of implementation and success. This a
Publikováno v:
ResearcherID
CONTEXT: Bronchopulmonary dysplasia (BPD) in preterm infants remains a major health burden despite many therapeutic interventions. Inhaled corticosteroids (IC) may be a safe and effective therapy. OBJECTIVE: To assess the safety and efficacy of IC fo
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::a8b2ddd202d205d1b7458ab0919fe748
https://www.zora.uzh.ch/id/eprint/129826/
https://www.zora.uzh.ch/id/eprint/129826/
Publikováno v:
Systematic Reviews
Background Inhaled steroids have been studied for both prevention and treatment of bronchopulmonary dysplasia (BPD). Results have been inconsistent. Recently, a large randomized controlled trial (RCT) has been reported. Methods/design We will perform
Autor:
Dan Reich, Maya Frank Wolf, Igor Portnov, David Peleg, Avi Peretz, Raed Salim, Dan Miron, Hagai Rechnitzer, Amir Koshnir, Yoram Keness, Inbar Ben Shachar, Moshe Ben Ami
Publikováno v:
American journal of perinatology. 32(13)
Objective The purpose of our study was to determine whether the current antibiotic regimen for preterm premature rupture of membranes (PPROM) is adequate for covering the current causative agents and sensitivities of chorioamnionitis and early-onset